Literature DB >> 11239029

Mesna: a novel renoprotective antioxidant in ischaemic acute renal failure.

E Mashiach1, S Sela, T Weinstein, H I Cohen, S M Shasha, B Kristal.   

Abstract

BACKGROUND: Reactive oxygen species (ROS) play a key role in renal ischaemia-reperfusion injury. After establishing the in vitro anti-oxidative potential of mesna, a sulfhydryl-containing compound, its effect on kidney function and morphology in a rat model of ischaemic acute renal failure (ARF) was examined.
METHODS: Mesna (180 mg/kg) was administered at different time points relative to ischaemia and/or reperfusion onset. Kidney function was assessed by glomerular filtration rate (GFR) and fractional sodium excretion (FE(Na)) before a 45-min period of unilateral renal artery clamping and following 90 min of reperfusion. Mesna was administered by bolus, 30 min before the induction of ischaemia, 5 min before ischaemia, 5 min before reperfusion, and 5 min after the onset of reperfusion.
RESULTS: Mesna improved function of the ischaemic kidney at each administration. When mesna was administered 5 min before the onset of reperfusion, GFR reached 90-100% of its pre ischaemic value and FE(Na) was improved by 75%. The beneficial effect of mesna was also demonstrated by light and electron microscopy. Kidneys treated with mesna 5 min before reperfusion resembled ischaemic non-reperfused kidneys and showed subtle morphological and ultrastructural changes compared with ischaemic-reperfused kidneys. Mesna had no haemodynamic effect on renal blood flow and did not induce any osmotic diuresis.
CONCLUSIONS: We suggest that mesna acts as an antioxidant. Its antioxidant potential together with optimal protection achieved when administered 5 min before reperfusion, supports the conclusion that mesna scavenges ROS generated at the onset of reperfusion, thus diminishing reperfusion injury and organ damage.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11239029     DOI: 10.1093/ndt/16.3.542

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  9 in total

1.  Curculigo orchioides Gaertn Effectively Ameliorates the Uro- and Nephrotoxicities Induced by Cyclophosphamide Administration in Experimental Animals.

Authors:  Vishnu Priya Murali; Girija Kuttan
Journal:  Integr Cancer Ther       Date:  2015-09-29       Impact factor: 3.279

2.  Protective effect of MESNA (2-mercaptoethane sulfonate) against hepatic ischemia/reperfusion injury in rats.

Authors:  Goksel Sener; Ozer Sehirli; Feriha Ercan; Serap Sirvanci; Nursal Gedik; Ayhan Kacmaz
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

Review 3.  Integrative emphases on intimate, intrinsic propensity/pathological processes--causes of self recovery limits and also, subtle related targets for neuroprotectionl pleiotropicity/multimodal actions, by accessible therapeutic approaches--in spinal cord injuries.

Authors:  G Onose; M Haras; A Anghelescu; D Mureşanu; C Giuglea; C Daia Chendreanu
Journal:  J Med Life       Date:  2010 Jul-Sep

4.  Effect of the antioxidant Mesna (2-mercaptoethane sulfonate) on experimental colitis.

Authors:  T Shusterman; S Sela; H Cohen; B Kristal; W Sbeit; R Reshef
Journal:  Dig Dis Sci       Date:  2003-06       Impact factor: 3.199

Review 5.  Novel Therapies for Acute Kidney Injury.

Authors:  Huaizhen Chen; Laurence William Busse
Journal:  Kidney Int Rep       Date:  2017-06-28

6.  A novel gold-nanocluster-based fluorescent sensor for detection of sodium 2-mercaptoethanesulfonate.

Authors:  Jiaxing Su; Chenchen Feng; Yuan Wu; Jiangong Liang
Journal:  RSC Adv       Date:  2019-06-17       Impact factor: 4.036

7.  Exploring antiviral and anti-inflammatory effects of thiol drugs in COVID-19.

Authors:  Kritika Khanna; Wilfred W Raymond; Jing Jin; Annabelle R Charbit; Irina Gitlin; Monica Tang; Adam D Werts; Edward G Barrett; Jason M Cox; Sharla M Birch; Rachel Martinelli; Hannah S Sperber; Sergej Franz; Thomas Duff; Markus Hoffmann; Anne Marie Healy; Stefan Oscarson; Stefan Pöhlmann; Satish K Pillai; Graham Simmons; John V Fahy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-06-28       Impact factor: 6.011

8.  Pharmacokinetic behaviour of the chemoprotectants BNP7787 and mesna after an i.v. bolus injection in rats.

Authors:  M Verschraagen; E Boven; E Torun; C A M Erkelens; F H Hausheer; W J F van der Vijgh
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

9.  Doxorubicin-induced elevated oxidative stress and neurochemical alterations in brain and cognitive decline: protection by MESNA and insights into mechanisms of chemotherapy-induced cognitive impairment ("chemobrain").

Authors:  Jeriel T R Keeney; Xiaojia Ren; Govind Warrier; Teresa Noel; David K Powell; Jennifer M Brelsfoard; Rukhsana Sultana; Kathryn E Saatman; Daret K St Clair; D Allan Butterfield
Journal:  Oncotarget       Date:  2018-07-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.